{
  "timestamp": "2025-09-15T21:21:20.069934",
  "total_test_cases": 8,
  "pipelines_evaluated": [
    "current_graphrag",
    "merged_graphrag",
    "basic_rag"
  ],
  "pipeline_scores": {},
  "pipeline_performance": {},
  "detailed_results": [
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_001",
      "question": "What are the primary mechanisms of insulin resistance in type 2 diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Insulin resistance in type 2 diabetes involves post-receptor defects in insulin signaling, \n                particularly affecting insulin receptor substrate (IRS) proteins and the PI3K pathway. This leads to \n                reduced GLUT4 translocation and decreased glucose uptake in peripheral tissues, especially muscle and \n                adipose tissue. Additionally, there is increased hepatic glucose production and impaired insulin signaling.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 125.68033300340176,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_002",
      "question": "How does metformin work to control blood glucose levels?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Metformin works by activating AMP-activated protein kinase (AMPK) through inhibition of \n                mitochondrial respiratory chain complex I. This leads to reduced hepatic gluconeogenesis, increased \n                peripheral glucose uptake in skeletal muscle, and improved insulin sensitivity. The drug also decreases \n                intestinal glucose absorption.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 253.03354195784777,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_003",
      "question": "What cardiovascular complications are associated with diabetes and how are they managed?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Cardiovascular disease is the leading cause of mortality in diabetes. Complications include \n                accelerated atherosclerosis, endothelial dysfunction, and increased thrombotic risk. Management involves \n                intensive glycemic control (HbA1c <7%), blood pressure control (<130/80 mmHg), lipid management with \n                statins (LDL <70 mg/dL), and consideration of antiplatelet therapy.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 278.3340000314638,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_004",
      "question": "How does COVID-19 affect patients with diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "COVID-19 significantly impacts diabetic patients, causing increased hospitalization rates and \n                mortality. This occurs due to compromised immune function, higher ACE2 receptor expression, chronic \n                inflammation, and increased thrombotic risk. COVID-19 can also cause new-onset diabetes by directly \n                damaging pancreatic beta cells through ACE2 receptor binding.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 176.21045792475343,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_005",
      "question": "What are the benefits and side effects of SGLT-2 inhibitors?",
      "answer": "",
      "contexts": [],
      "ground_truth": "SGLT-2 inhibitors provide glycemic control by blocking glucose reabsorption in the kidney. \n                Beyond glucose lowering, they offer cardiovascular benefits (reduced heart failure risk) and renal \n                protection (slower diabetic nephropathy progression). Side effects include genital infections and UTIs. \n                Rare serious effects include diabetic ketoacidosis and Fournier's gangrene.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 329.32495803106576,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_006",
      "question": "What causes beta-cell dysfunction in type 2 diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Beta-cell dysfunction in type 2 diabetes results from multiple factors including glucotoxicity, \n                lipotoxicity, inflammatory cytokines, and amyloid deposition. This leads to reduced insulin secretion in \n                response to glucose, loss of first-phase insulin release, and eventual beta-cell apoptosis.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 314.9674590677023,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_007",
      "question": "What are the contraindications for metformin use?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Metformin is contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m\u00b2) due to \n                increased risk of lactic acidosis. It should also be temporarily discontinued during acute illness, \n                dehydration, or conditions that may predispose to lactic acidosis.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 414.49741704855114,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "current_graphrag",
      "test_case_id": "test_008",
      "question": "What specific management changes are needed for diabetic patients with COVID-19?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Diabetic patients with COVID-19 require more frequent glucose monitoring, potential temporary \n                insulin therapy even for non-insulin dependent patients, telemedicine for care continuity, and prioritization \n                for vaccination. Metformin should be temporarily discontinued during acute illness due to lactic acidosis risk.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 426.4819170348346,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_001",
      "question": "What are the primary mechanisms of insulin resistance in type 2 diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Insulin resistance in type 2 diabetes involves post-receptor defects in insulin signaling, \n                particularly affecting insulin receptor substrate (IRS) proteins and the PI3K pathway. This leads to \n                reduced GLUT4 translocation and decreased glucose uptake in peripheral tissues, especially muscle and \n                adipose tissue. Additionally, there is increased hepatic glucose production and impaired insulin signaling.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 464.48991703800857,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_002",
      "question": "How does metformin work to control blood glucose levels?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Metformin works by activating AMP-activated protein kinase (AMPK) through inhibition of \n                mitochondrial respiratory chain complex I. This leads to reduced hepatic gluconeogenesis, increased \n                peripheral glucose uptake in skeletal muscle, and improved insulin sensitivity. The drug also decreases \n                intestinal glucose absorption.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 437.2921249596402,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_003",
      "question": "What cardiovascular complications are associated with diabetes and how are they managed?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Cardiovascular disease is the leading cause of mortality in diabetes. Complications include \n                accelerated atherosclerosis, endothelial dysfunction, and increased thrombotic risk. Management involves \n                intensive glycemic control (HbA1c <7%), blood pressure control (<130/80 mmHg), lipid management with \n                statins (LDL <70 mg/dL), and consideration of antiplatelet therapy.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 407.5197499478236,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_004",
      "question": "How does COVID-19 affect patients with diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "COVID-19 significantly impacts diabetic patients, causing increased hospitalization rates and \n                mortality. This occurs due to compromised immune function, higher ACE2 receptor expression, chronic \n                inflammation, and increased thrombotic risk. COVID-19 can also cause new-onset diabetes by directly \n                damaging pancreatic beta cells through ACE2 receptor binding.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 193.44158400781453,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_005",
      "question": "What are the benefits and side effects of SGLT-2 inhibitors?",
      "answer": "",
      "contexts": [],
      "ground_truth": "SGLT-2 inhibitors provide glycemic control by blocking glucose reabsorption in the kidney. \n                Beyond glucose lowering, they offer cardiovascular benefits (reduced heart failure risk) and renal \n                protection (slower diabetic nephropathy progression). Side effects include genital infections and UTIs. \n                Rare serious effects include diabetic ketoacidosis and Fournier's gangrene.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 472.5371249951422,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_006",
      "question": "What causes beta-cell dysfunction in type 2 diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Beta-cell dysfunction in type 2 diabetes results from multiple factors including glucotoxicity, \n                lipotoxicity, inflammatory cytokines, and amyloid deposition. This leads to reduced insulin secretion in \n                response to glucose, loss of first-phase insulin release, and eventual beta-cell apoptosis.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 116.73508305102587,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_007",
      "question": "What are the contraindications for metformin use?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Metformin is contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m\u00b2) due to \n                increased risk of lactic acidosis. It should also be temporarily discontinued during acute illness, \n                dehydration, or conditions that may predispose to lactic acidosis.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 411.33808298036456,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "merged_graphrag",
      "test_case_id": "test_008",
      "question": "What specific management changes are needed for diabetic patients with COVID-19?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Diabetic patients with COVID-19 require more frequent glucose monitoring, potential temporary \n                insulin therapy even for non-insulin dependent patients, telemedicine for care continuity, and prioritization \n                for vaccination. Metformin should be temporarily discontinued during acute illness due to lactic acidosis risk.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 439.97958407271653,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_001",
      "question": "What are the primary mechanisms of insulin resistance in type 2 diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Insulin resistance in type 2 diabetes involves post-receptor defects in insulin signaling, \n                particularly affecting insulin receptor substrate (IRS) proteins and the PI3K pathway. This leads to \n                reduced GLUT4 translocation and decreased glucose uptake in peripheral tissues, especially muscle and \n                adipose tissue. Additionally, there is increased hepatic glucose production and impaired insulin signaling.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 500.65079191699624,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_002",
      "question": "How does metformin work to control blood glucose levels?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Metformin works by activating AMP-activated protein kinase (AMPK) through inhibition of \n                mitochondrial respiratory chain complex I. This leads to reduced hepatic gluconeogenesis, increased \n                peripheral glucose uptake in skeletal muscle, and improved insulin sensitivity. The drug also decreases \n                intestinal glucose absorption.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 147.93883298989385,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_003",
      "question": "What cardiovascular complications are associated with diabetes and how are they managed?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Cardiovascular disease is the leading cause of mortality in diabetes. Complications include \n                accelerated atherosclerosis, endothelial dysfunction, and increased thrombotic risk. Management involves \n                intensive glycemic control (HbA1c <7%), blood pressure control (<130/80 mmHg), lipid management with \n                statins (LDL <70 mg/dL), and consideration of antiplatelet therapy.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 112.20033303834498,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_004",
      "question": "How does COVID-19 affect patients with diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "COVID-19 significantly impacts diabetic patients, causing increased hospitalization rates and \n                mortality. This occurs due to compromised immune function, higher ACE2 receptor expression, chronic \n                inflammation, and increased thrombotic risk. COVID-19 can also cause new-onset diabetes by directly \n                damaging pancreatic beta cells through ACE2 receptor binding.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 333.74195802025497,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_005",
      "question": "What are the benefits and side effects of SGLT-2 inhibitors?",
      "answer": "",
      "contexts": [],
      "ground_truth": "SGLT-2 inhibitors provide glycemic control by blocking glucose reabsorption in the kidney. \n                Beyond glucose lowering, they offer cardiovascular benefits (reduced heart failure risk) and renal \n                protection (slower diabetic nephropathy progression). Side effects include genital infections and UTIs. \n                Rare serious effects include diabetic ketoacidosis and Fournier's gangrene.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 257.2735840221867,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_006",
      "question": "What causes beta-cell dysfunction in type 2 diabetes?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Beta-cell dysfunction in type 2 diabetes results from multiple factors including glucotoxicity, \n                lipotoxicity, inflammatory cytokines, and amyloid deposition. This leads to reduced insulin secretion in \n                response to glucose, loss of first-phase insulin release, and eventual beta-cell apoptosis.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 235.5120829306543,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_007",
      "question": "What are the contraindications for metformin use?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Metformin is contraindicated in severe renal impairment (eGFR <30 mL/min/1.73m\u00b2) due to \n                increased risk of lactic acidosis. It should also be temporarily discontinued during acute illness, \n                dehydration, or conditions that may predispose to lactic acidosis.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 123.01841692533344,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    },
    {
      "pipeline_name": "basic_rag",
      "test_case_id": "test_008",
      "question": "What specific management changes are needed for diabetic patients with COVID-19?",
      "answer": "",
      "contexts": [],
      "ground_truth": "Diabetic patients with COVID-19 require more frequent glucose monitoring, potential temporary \n                insulin therapy even for non-insulin dependent patients, telemedicine for care continuity, and prioritization \n                for vaccination. Metformin should be temporarily discontinued during acute illness due to lactic acidosis risk.",
      "answer_correctness": 0.0,
      "faithfulness": 0.0,
      "context_precision": 0.0,
      "context_recall": 0.0,
      "answer_relevance": 0.0,
      "execution_time_ms": 236.8189999833703,
      "retrieval_time_ms": 0.0,
      "generation_time_ms": 0.0,
      "success": false,
      "error_message": "name 'p_type' is not defined",
      "metadata": {}
    }
  ],
  "best_pipeline": "",
  "improvement_recommendations": [],
  "target_achievement": {},
  "summary": "RAGAS Evaluation Summary:\n- Best performing pipeline: \n- Pipelines meeting all targets: 0/0"
}